I've been following NVAX since price was at $12. Fundamentally they have one of the most promising COVID vaccines and their Nano Flu shot beat Sanify's flu shot, whos been a market majority holder in that aspect.
Technically, we've tapped that $150+ zone 8 out of the last 9 fast rises over since the company IPO'd in 1996. Each of the rises have been driven by pandemic viruses..ie, swine flu, bird flu, H1N1, etc.
We have 4 days until the quarterly candle closes. If we close strong, we'd of closed above the coral, and momentum and RSI are correlating. I think we will see a short term sell off at the psychological $100 level. How much? I could see $80-$85 be a good rebuy zone to push price up to t $125 then $150. Buyers at $80, will probably be looking for a double on their investment which would put price at $160.
Let me know what you think!
Technically, we've tapped that $150+ zone 8 out of the last 9 fast rises over since the company IPO'd in 1996. Each of the rises have been driven by pandemic viruses..ie, swine flu, bird flu, H1N1, etc.
We have 4 days until the quarterly candle closes. If we close strong, we'd of closed above the coral, and momentum and RSI are correlating. I think we will see a short term sell off at the psychological $100 level. How much? I could see $80-$85 be a good rebuy zone to push price up to t $125 then $150. Buyers at $80, will probably be looking for a double on their investment which would put price at $160.
Let me know what you think!